Target Information
Ascent Equity Partners (Ascent EP) and Welcome Capital are set to invest 30 billion KRW in Wontec, a publicly listed company on the KOSDAQ, known for manufacturing medical devices focused on skin aesthetics. This investment aims to facilitate equipment upgrades and support Wontec's overseas expansion plans. According to investment banking sources, Ascent EP and Welcome Capital will acquire 30 billion KRW worth of convertible bonds issued by Wontec. They are currently in the process of forming a co-managed project fund and have completed fundraising efforts, with deal closing imminent. Wontec has also finalized its plans for the issuance of these bonds in its recent board meeting.
Founded in 1999, Wontec has developed a range of laser devices over the past two decades, significantly expanding its offerings in the aesthetic medical devices sector. Initially established as 'Wontechnology,' the company produces devices that utilize energy methods such as aesthetic lasers, radiofrequency (RF), and high-intensity focused ultrasound (HIFU) to achieve non-invasive skin improvement results like collagen regeneration, tightening, and lifting. The company became listed on the KOSDAQ market in June 2020 after being listed on KONEX in April 2015.
Industry Overview
The South Korean medical device industry is characterized by rapid growth and innovation, particularly in the aesthetic segment. With increasing consumer awareness and demand for non-invasive beauty treatments, companies like Wontec are positioned favorably. The South Korean government has been actively supporting the medical device sector through various initiatives that promote research and development, fostering a conducive environment for startups and established firms alike.
The global market for aesthetic medical devices is anticipated to witness exponential growth, driven by technological advancements and the rising beauty trend among consumers. South Korea leads in the innovation of medical technologies and has established itself as a hub for aesthetic procedures, resulting in a vibrant ecosystem for related businesses.
South Korean medical device manufacturers face both opportunities and challenges when venturing into international markets. While robust demand exists, especially in regions like North America and Europe, companies must navigate regulatory hurdles and establish strong distribution channels to succeed. Wontec's recent FDA approval for their flagship product signifies a pivotal step toward overcoming these barriers in the U.S. market.
Wontec's strategies for expansion also underscore their commitment to tapping into potential markets such as South America, Africa, Japan, China, and the M…